Skip to main content
Home
  • en
  • fr
  • Profile
    • About DEINOVE
    • Board of Directors
    • Executive Committee
    • Founders
    • A word from the CEO
  • Antibiotics
    • About
    • Antimicrobial resistance
    • Portfolio
    • The AGIR program
    • Discovery platform
    • Partners
  • Bioactives
    • About
    • Biodiversity
    • Portfolio
    • Platform of Expertise
    • Partners
  • Investor room
    • Corporate governance
    • DEINOVE Shares
    • Financial Calendar
    • Documentation Center
    • Press releases
    • Investor relations
  • News & events
    • Press releases
    • Events
    • Press coverage
  • Careers
    • Join DEINOVE
    • Open positions
  1. Home
  2. Investor room
  3. Documentation Center
  4. Shareholders' Meetings
  5. Extraordinary Shareholders' Meeting | 11 December, 2019

Extraordinary Shareholders' Meeting | 11 December, 2019

An Extraordinary General meeting is convened on 11 December, 2019 at 14:00, at the premises of Fieldfisher Paris – 48 rue Cambon, 75001 Paris, France.

 

 

Meeting notice (BALO) - 25 November 2019 (in French)
Resolutions (in French)
Total number of shares and voting rights at the date of the publication of the notice of meeting (25 Nov. 2019) (in French)
Voting by post / by proxy form (in French)
Information request form (in French)
Admission card request form (in French)
Meeting notice (BALO) - 6 November 2019 (in French)

Investor room

  • Corporate governance
    • Board of Directors
    • Executive Committee
  • DEINOVE Shares
  • Financial Calendar
  • Documentation Center
    • Financial Reports
    • Investor presentations
    • Analyst Coverage
    • Newsletter to Shareholders
    • Shareholders' Meetings
    • Shares and Voting Rights
    • Transactions on company securities
    • Liquidity Agreement
    • Public offerings - Documentation
    • Obligations Convertibles en Actions (OCA)
  • Press releases
  • Investor relations
  • Contact
  • Location
  • Legal Info
  • Site map
  • Privacy Policy

Profile

  • About DEINOVE
  • Board of Directors
  • Executive Committee
  • Founders
  • A word from the CEO

Antibiotics

  • About
  • Antimicrobial resistance
  • Portfolio
  • The AGIR program
  • Discovery platform
  • Partners

Bioactives

  • About
  • Biodiversity
  • Portfolio
  • Platform of Expertise
  • Partners

Investor room

  • Corporate governance
  • DEINOVE Shares
  • Financial Calendar
  • Documentation Center
    • Financial Reports
    • Investor presentations
    • Analyst Coverage
    • Newsletter to Shareholders
    • Shareholders' Meetings
      • Extraordinary Shareholders' Meeting | 5 December, 2019
      • Annual Shareholders' Meeting | May 20, 2019
    • Shares and Voting Rights
    • Transactions on company securities
    • Liquidity Agreement
    • Public offerings - Documentation
    • Obligations Convertibles en Actions (OCA)
  • Press releases
  • Investor relations

Careers

  • Join DEINOVE
  • Open positions

News & events

  • Press releases
  • Events
  • Press coverage

Downloads

  • Investor presentations
  • Analyst Coverage
  • Financial Reports

Follow us

Stay in touch

Subscribe to our newsletter

Contact us

ZAC Euromédecine II, Cap Sigma, 1682 Rue de la Valsière, 34790 Grabels, France

+33 (0)4 48 19 01 00

Home